1495 related articles for article (PubMed ID: 11427266)
1. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
[TBL] [Abstract][Full Text] [Related]
2. Low occurrence of HBsAg but high frequency of transient occult HBV infection in vaccinated and HBIG-administered infants born to HBsAg positive mothers.
Zhou S; Li T; Allain JP; Zhou B; Zhang Y; Zhong M; Fu Y; Li C
J Med Virol; 2017 Dec; 89(12):2130-2137. PubMed ID: 28543299
[TBL] [Abstract][Full Text] [Related]
3. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
[TBL] [Abstract][Full Text] [Related]
4. [Atypical serological profiles in hepatitis B infections: investigation of S gene mutations in cases with concurrently positive for HBsAg and anti-HBs].
Aydın N; Kırdar S; Uzun N; Eyigör M; Sayan M
Mikrobiyol Bul; 2016 Oct; 50(4):535-543. PubMed ID: 28124958
[TBL] [Abstract][Full Text] [Related]
5. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between the HBsAg-positive infection status of mothers and the non/low-response to hepatitis B vaccine of their infants].
Yang ZQ; Hao HY; Shi XH; Fu ZD; Zhang F; Wang XF; Xu XX; Wang B; Wen HX; Feng SY; Wang B; Wang SP
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):805-809. PubMed ID: 29936751
[No Abstract] [Full Text] [Related]
7. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
[TBL] [Abstract][Full Text] [Related]
8. Reduced detection and levels of protective antibodies to hepatitis B vaccine in under 2-year-old HIV positive South African children at a paediatric outpatient clinic.
Simani OE; Leroux-Roels G; François G; Burnett RJ; Meheus A; Mphahlele MJ
Vaccine; 2009 Jan; 27(1):146-51. PubMed ID: 18940220
[TBL] [Abstract][Full Text] [Related]
9. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
[TBL] [Abstract][Full Text] [Related]
10. Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region.
Poovorawan Y; Chongsrisawat V; Theamboonlers A; Leroux-Roels G; Kuriyakose S; Leyssen M; Jacquet JM
J Viral Hepat; 2011 May; 18(5):369-75. PubMed ID: 20384962
[TBL] [Abstract][Full Text] [Related]
11. Occult hepatitis B virus infection in children born to HBsAg-positive mothers after neonatal passive-active immunoprophylaxis.
Foaud H; Maklad S; Mahmoud F; El-Karaksy H
Infection; 2015 Jun; 43(3):307-14. PubMed ID: 25665956
[TBL] [Abstract][Full Text] [Related]
12. Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda.
Seremba E; Van Geertruyden JP; Ssenyonga R; Opio CK; Kaducu JM; Sempa JB; Colebunders R; Ocama P
Vaccine; 2017 May; 35(22):2937-2942. PubMed ID: 28434689
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study of hepatitis B mother-to-child transmission prevention and postvaccination serological test results of infants at risk of perinatal transmission in two counties of middle China.
Yonghao G; Pumei D; Jianhui Y; Jin X; Yanyang Z; Zhe W
J Viral Hepat; 2017 Aug; 24(8):687-695. PubMed ID: 28199772
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of active and occult hepatitis B virus infections in healthcare workers from two provinces of South Africa.
Sondlane TH; Mawela L; Razwiedani LL; Selabe SG; Lebelo RL; Rakgole JN; Mphahlele MJ; Dochez C; De Schryver A; Burnett RJ
Vaccine; 2016 Jul; 34(33):3835-9. PubMed ID: 27265453
[TBL] [Abstract][Full Text] [Related]
16. Continuing Decrease in Hepatitis B Virus Infection 30 Years After Initiation of Infant Vaccination Program in Taiwan.
Ni YH; Chang MH; Jan CF; Hsu HY; Chen HL; Wu JF; Chen DS
Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1324-30. PubMed ID: 27155556
[TBL] [Abstract][Full Text] [Related]
17. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.
Boot HJ; Hahné S; Cremer J; Wong A; Boland G; van Loon AM
J Viral Hepat; 2010 Dec; 17(12):872-8. PubMed ID: 20051008
[TBL] [Abstract][Full Text] [Related]
18. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
Mphahlele MJ; Lukhwareni A; Burnett RJ; Moropeng LM; Ngobeni JM
J Clin Virol; 2006 Jan; 35(1):14-20. PubMed ID: 15916918
[TBL] [Abstract][Full Text] [Related]
19. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals.
Da Villa G; Romanò L; Sepe A; Iorio R; Paribello N; Zappa A; Zanetti AR
Vaccine; 2007 Apr; 25(16):3133-6. PubMed ID: 17280750
[TBL] [Abstract][Full Text] [Related]
20. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B.
Grosheide PM; del Canho R; Voogd M; Heijtink RA; Schalm SW
Vaccine; 1994 Sep; 12(12):1059-63. PubMed ID: 7998413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
